Longitudinal head-to-head comparison of 11C-PiB and 18F-florbetapir PET in a Phase 2/3 clinical trial of anti-amyloid-β monoclonal antibodies in dominantly inherited Alzheimer’s disease
- DOI
- 10.1007/s00259-023-06209-0
- Published
- 2023-04-05
- Container
- European Journal of Nuclear Medicine and Molecular Imaging
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s00259-023-06209-0,
title = {Longitudinal head-to-head comparison of 11C-PiB and 18F-florbetapir PET in a Phase 2/3 clinical trial of anti-amyloid-β monoclonal antibodies in dominantly inherited Alzheimer’s disease},
author = {Charles D. Chen and Austin McCullough and Brian Gordon and Nelly Joseph-Mathurin and Shaney Flores and Nicole S. McKay and Diana A. Hobbs and Russ Hornbeck and Anne M. Fagan and Carlos Cruchaga and Alison M. Goate and Richard J. Perrin and Guoqiao Wang and Yan Li and Xinyu Shi and Chengjie Xiong and Michael J. Pontecorvo and Gregory Klein and Yi Su and William E. Klunk and Clifford Jack and Robert Koeppe and B. Joy Snider and Sarah B. Berman and Erik D. Roberson and Jared Brosch and Ghulam Surti and Ivonne Z. Jiménez-Velázquez and Douglas Galasko and Lawrence S. Honig and William S. Brooks and Roger Clarnette and David Wallon and Bruno Dubois and Jérémie Pariente and Florence Pasquier and Raquel Sanchez-Valle and Sergey Shcherbinin and Ixavier Higgins and Ilke Tunali and Colin L. Masters and Christopher H. van Dyck and Mario Masellis and Robin Hsiung and Serge Gauthier and Steve Salloway and David B. Clifford and Susan Mills and Charlene Supnet-Bell and Eric McDade and Randall J. Bateman and Tammie L. S. Benzinger and Unknown},
year = {2023},
journal = {European Journal of Nuclear Medicine and Molecular Imaging},
doi = {10.1007/s00259-023-06209-0},
url = {https://doi.org/10.1007/s00259-023-06209-0}
}RIS
TY - JOUR TI - Longitudinal head-to-head comparison of 11C-PiB and 18F-florbetapir PET in a Phase 2/3 clinical trial of anti-amyloid-β monoclonal antibodies in dominantly inherited Alzheimer’s disease AU - Charles D. Chen AU - Austin McCullough AU - Brian Gordon AU - Nelly Joseph-Mathurin AU - Shaney Flores AU - Nicole S. McKay AU - Diana A. Hobbs AU - Russ Hornbeck AU - Anne M. Fagan AU - Carlos Cruchaga AU - Alison M. Goate AU - Richard J. Perrin AU - Guoqiao Wang AU - Yan Li AU - Xinyu Shi AU - Chengjie Xiong AU - Michael J. Pontecorvo AU - Gregory Klein AU - Yi Su AU - William E. Klunk AU - Clifford Jack AU - Robert Koeppe AU - B. Joy Snider AU - Sarah B. Berman AU - Erik D. Roberson AU - Jared Brosch AU - Ghulam Surti AU - Ivonne Z. Jiménez-Velázquez AU - Douglas Galasko AU - Lawrence S. Honig AU - William S. Brooks AU - Roger Clarnette AU - David Wallon AU - Bruno Dubois AU - Jérémie Pariente AU - Florence Pasquier AU - Raquel Sanchez-Valle AU - Sergey Shcherbinin AU - Ixavier Higgins AU - Ilke Tunali AU - Colin L. Masters AU - Christopher H. van Dyck AU - Mario Masellis AU - Robin Hsiung AU - Serge Gauthier AU - Steve Salloway AU - David B. Clifford AU - Susan Mills AU - Charlene Supnet-Bell AU - Eric McDade AU - Randall J. Bateman AU - Tammie L. S. Benzinger AU - Unknown PY - 2023 JO - European Journal of Nuclear Medicine and Molecular Imaging DO - 10.1007/s00259-023-06209-0 UR - https://doi.org/10.1007/s00259-023-06209-0 ER -
APA
Chen, C. D., McCullough, A., Gordon, B., Joseph-Mathurin, N., Flores, S., McKay, N. S., Hobbs, D. A., Hornbeck, R., Fagan, A. M., Cruchaga, C., Goate, A. M., Perrin, R. J., Wang, G., Li, Y., Shi, X., Xiong, C., Pontecorvo, M. J., Klein, G., Su, Y., Klunk, W. E., Jack, C., Koeppe, R., Snider, B. J., Berman, S. B., Roberson, E. D., Brosch, J., Surti, G., Jiménez-Velázquez, I. Z., Galasko, D., Honig, L. S., Brooks, W. S., Clarnette, R., Wallon, D., Dubois, B., Pariente, J., Pasquier, F., Sanchez-Valle, R., Shcherbinin, S., Higgins, I., Tunali, I., Masters, C. L., Dyck, C. H. V., Masellis, M., Hsiung, R., Gauthier, S., Salloway, S., Clifford, D. B., Mills, S., Supnet-Bell, C., McDade, E., Bateman, R. J., Benzinger, T. L. S., & Unknown (2023). Longitudinal head-to-head comparison of 11C-PiB and 18F-florbetapir PET in a Phase 2/3 clinical trial of anti-amyloid-β monoclonal antibodies in dominantly inherited Alzheimer’s disease. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-023-06209-0
Source records
- crossref · retrieved 2026-09-26T10:33:34.637Z